Skip to content

The Comparison of a Technology-Based System and an In-Person Behavioral Weight Loss Intervention

The Comparison of a Technology-Based System and an In-Person Behavioral Weight Loss Intervention

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01134874
Enrollment
51
Registered
2010-06-02
Start date
2009-08-31
Completion date
2010-09-30
Last updated
2015-08-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity

Brief summary

The primary aim of this study is to compare the changes in body weight between a technology-based system, an in-person behavioral weight loss intervention, and a combination of both during a 12 month behavioral weight loss intervention in adults. Sedentary, healthy overweight and obese adults will be recruited to participate. Assessments will be conducted at 0, 6, and 12 months. This is a randomized trial in which participants will be randomized to one of three groups: standard behavioral weight loss (SBWL), standard behavioral weight loss plus technology (SBWL+TECH), and technology alone alone (TECH).

Interventions

In-person weight loss sessions, dietary intake prescription of 1200-1500 kcal per day, exercise progressing to 300 minutes per week.

BEHAVIORALStandard weight loss intervention plus technology

In-person weight loss sessions, dietary intake prescription of 1200-1500 kcal per day, exercise progressing to 300 minutes per week, plus technology to provide real-time feedback on energy expenditure, plus a website to log dietary intake.

BEHAVIORALTechnology only

One intervention telephone call per month, dietary intake prescription of 1200-1500 kcal per day, exercise progressing to 300 minutes per week, plus technology to provide real-time feedback on energy expenditure, plus a website to log dietary intake.

Sponsors

John M. Jakicic, PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* ages of 21-55 years * Body mass index (BMI) between 25-39.9 kg/m2

Exclusion criteria

* Currently pregnant, pregnant in the last 6 months, or plan on becoming pregnant in the next 6 months. * Currently participating in regular exercise for over 60 minutes/week. * Taking any medications that affect body weight or metabolism (e.g. synthroid). * Have any physical limitations that would prevent exercise. * Currently being treated for coronary heart disease, diabetes mellitus, hypertension, or cancer. * Have a history of myocardial infarction or other heart-related surgeries. * Have a resting systolic blood pressure \> 150 mmHg or diastolic blood pressure of \> 100 mmHg or currently taking any medications that affect blood pressure or heart rate (e.g. beta blockers). * Currently enrolled in a commercial weight loss program, participating in another weight loss study, or in a weight loss study in the last 12 months. * Have lost \> 5% of current body weight in the past 6 months. * Currently being treated for any psychological problems or taking any psychotropic medication. * Currently do not have access to a computer and the Internet that can be used for this study. This requires a PC computer, the ability to load software for the technology system, an existing internet connection provided by the participant, and a dedicated USB port to allow the armband from the technology system to be connected to the computer for the download of information.

Design outcomes

Primary

MeasureTime frameDescription
weightchange from 0 to 6 monthsBody weight will be assessed on a digital scale to assess change in body weight over the intervention period.

Secondary

MeasureTime frameDescription
body composition0, 6, 12 monthsBody composition will be assessed using dual energy X-ray absorptiometry (DXA). This will provide a measure of lean body mass, fat mass, bone mineral content, and percent body fat.
physical activity0, 6, 12 monthsA questionnaire and a portable device worn on the upper arm will be used to measure and quantify energy expenditure from physical activity.
cardiorespiratory fitness0, 6, 12, monthsA graded exercise test on a treadmill along with indirect calorimetry will be used to measure cardiorespiratory fitness. This will provide a measure of oxygen consumption and metabolic equivalents of work at the time of test termination.
psychosocial and behavioral measures0, 6, 12 monthsQuestionnaires will be used to assess self-efficacy for weight loss and physical activity, barriers to physical activity and weight loss, expected outcomes resulting from physical activity and weight loss, perceived body image, depressive symptomotology, weight history, dietary disinhibition and restraint, and behaviors typically related to weight loss (e.g., self-weighing, meal planning, etc.).
Weight changeweight at 0, 6, and 12 monthsBody weight measured on a digital scale
dietary intake0, 6, 12 monthsA questionnaire will be used to assess self-reported food intake. This will be used to estimate calories, dietary fat, protein, and carbohydrates consumed.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026